Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
SEER
#3273
Seer, Inc. Class A Common Stock
1.7
2
-16.50%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-16.50%
Monatliche Änderung
-9.47%
6 month change
-16.50%
Jahresänderung
-20.74%
Vorheriger Schlusskurs
2.0
6
Open
1.7
2
Bid
Ask
Low
1.7
2
High
1.7
2
Volumen
15
Märkte
Aktien
Gesundheitswesen
SEER
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Total assets
383.42 M
366.6 M
347.26 M
322.49 M
308.61 M
Total liabilities
38.7 M
39.03 M
36.26 M
34.2 M
36.79 M
Total equity
344.73 M
327.57 M
311.01 M
288.29 M
271.81 M
Total liabilities & shareholders' equities
383.42 M
366.6 M
347.26 M
322.49 M
308.61 M
Total debt
—
—
—
—
—
Net debt
—
—
—
—
—
Seer Inc - Class A
Seer, Inc. is an American biotechnology company headquartered in Redwood City, California. Established in 2017, the company develops technologies for proteomics research.
Nachrichten
Seer, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:SEER) 2026-02-27
Seer, Inc. (SEER) Q4 2025 Earnings Call Transcript
Seer’in 4Ç 2025 sunumu: kurulu cihaz tabanı %67 arttı, gelir hedefi tutmadı
Seer Q4 2025 slides: installed base surges 67%, revenue misses mark
Seer kazancı $0,02 ile beklentilere göre daha iyi, kâr ise beklentilere göre düşük
Seer earnings beat by $0.02, revenue fell short of estimates
Seer to showcase proteomics technology at US HUPO conference
İlaç keşfi için protein-gen ilişkilerini doğrulayan kütle spektrometrisi çalışması
Mass spectrometry study validates protein-gene associations for drug discovery
Seer, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:SEER) 2025-11-26
CG MedTech Forumu’nda Seer: Proteomik Yenilikleri Öncülük Ediyor
Seer at CG MedTech Forum: Proteomics Innovations Lead the Way